CNR1 and FAAH variation and affective states induced by marijuana smoking

References

• Substance Abuse and Mental Health Services Administration. Results from the 2013 national survey on drug use and health: Summary of national findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
   Google Scholar
• Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. Jama. 2004;291(17):2114–21. doi:10.1001/jama.291.17.2114.
   PubMed Web of Science ®Google Scholar
• Benyamina A, Kebir O, Blecha L, Reynaud M, Krebs M-O. CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol. 2011;16(1):1–6. doi:10.1111/j.1369-1600.2009.00198.x.
   PubMed Web of Science ®Google Scholar
• Bühler K-M, Huertas E, Echeverry-Alzate V, Giné E, Moltó E, Montoliu L, López-Moreno JA. Risky alcohol consumption in young people is associated with the fatty acid amide hydrolase gene polymorphism C385A and affective rating of drug pictures. Mol Genet Genomics MGG. 2014;289(3):279–89. doi:10.1007/s00438-013-0809-x.
   PubMed Web of Science ®Google Scholar
• Marcos M, Pastor I, de la Calle C, Barrio-Real L, Laso F-J, González-Sarmiento R. Cannabinoid receptor 1 gene is associated with alcohol dependence. Alcohol Clin Exp Res. 2012;36(2):267–71. doi:10.1111/j.1530-0277.2011.01623.x.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Lynskey MT. The genetic epidemiology of cannabis use, abuse and dependence. Addiction. 2006;101(6):801–12. doi:10.1111/j.1360-0443.2006.01399.x.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Lynskey MT. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction. 2009;104(4):518–32. doi:10.1111/j.1360-0443.2009.02504.x.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Wetherill L, Dick DM, Xuei X, Hinrichs A, Hesselbrock V, Kramer J, Nurnberger JI, Schuckit M, Bierut LJ, et al. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Am J Med Genet Part B Neuropsychiatr Genet Off Pub Int Soc Psychiatric Genet. 2009;150B(5):736–40. doi:10.1002/ajmg.b.30881.
   PubMed Web of Science ®Google Scholar
• Hopfer CJ, Young SE, Purcell S, Crowley TJ, Stallings MC, Corley RP, Rhee SH, Smolen A, Krauter K, Hewitt JK, et al. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Am J Med Genet Part B Neuropsychiatr Genet Off Pub Int Soc Psychiatric Genet. 2006;141B(8):895–901. doi:10.1002/ajmg.b.30378.
   PubMed Web of Science ®Google Scholar
• Schacht JP, Hutchison KE, Filbey FM. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2012;37(11):2368–76. doi:10.1038/npp.2012.92.
   PubMed Web of Science ®Google Scholar
• Schacht JP, Selling RE, Hutchison KE. Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. Psychopharmacology. 2009;203(3):511–17. doi:10.1007/s00213-008-1397-z.
   PubMed Web of Science ®Google Scholar
• Bidwell LC, Metrik J, McGeary J, Palmer RH, Francazio S, Knopik VS. Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems. J Stud Alcohol Drugs. 2013;74(6):867–78.
   PubMed Web of Science ®Google Scholar
• Ashenhurst JR, Harden KP, Mallard TT, Corbin WR, Fromme K. Developmentally specific associations between CNR1 genotype and Cannabis use across emerging adulthood. J Stud Alcohol Drugs. 2017;78(5):686–95.
   PubMed Web of Science ®Google Scholar
• Tyndale RF, Payne JI, Gerber AL, Sipe JC. The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: studies of drug use and dependence in Caucasians. Am J Med Genet Part B Neuropsychiatr Genet Off Pub Int Soc Psychiatric Genet. 2007;144B(5):660–66. doi:10.1002/ajmg.b.30491.
   PubMed Web of Science ®Google Scholar
• Sipe JC, Chiang K, Gerber AL, Beutler E, Cravatt BF. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci USA. 2002;99(12). 8394–99. doi:10.1073/pnas.082235799.
   PubMed Web of Science ®Google Scholar
• Flanagan JM, Gerber AL, Cadet JL, Beutler E, Sipe JC. The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Hum Genet. 2006;120(4):581–88. doi:10.1007/s00439-006-0250-x.
   PubMed Web of Science ®Google Scholar
• Stringer S, Minica CC, Verweij KJ, Mbarek H, Bernard M, Derringer J, van Eijk KR, Isen JD, Loukola A, Maciejewski DF, et al. Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium. Transl Psychiatry. 2016;6:e769. doi:10.1038/tp.2016.36.
   PubMed Web of Science ®Google Scholar
• Sherva R, Wang Q, Kranzler H, Zhao H, Koesterer R, Herman A, Farrer LA. Genome-wide association study of Cannabis dependence severity, novel risk variants, and shared genetic risks. JAMA Psychiatry. 2016;73(5):472–80. doi:10.1001/jamapsychiatry.2016.0036.
   PubMed Web of Science ®Google Scholar
• Palmer RH, Brick L, Nugent NR, Bidwell LC, McGeary JE, Knopik VS, Keller MC. Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence. Addiction. 2015;110(3):530–37. doi:10.1111/add.12815.
   PubMed Web of Science ®Google Scholar
• Goldman D. The missing heritability of behavior: the search continues. Psychophysiology. 2014;51(12):1327–28. doi:10.1111/psyp.12362.
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747–53. doi:10.1038/nature08494.
   PubMed Web of Science ®Google Scholar
• Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE, Filbey Fm, Schacht Jp, Myers Us, Chavez Rs, Hutchison Ke. Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2010;35(4):967–75. doi:10.1038/npp.2009.200.
   PubMed Web of Science ®Google Scholar
• Dean B, Sundram S, Bradbury R, Scarr E, Copolov D. Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience. 2001;103(1):9–15.
   PubMed Web of Science ®Google Scholar
• Zavitsanou K, Garrick T, Huang XF. Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(2):355–60. doi:10.1016/j.pnpbp.2003.11.005.
   PubMed Web of Science ®Google Scholar
• Hill SY, Sharma V, Jones BL. Lifetime use of cannabis from longitudinal assessments, cannabinoid receptor (CNR1) variation, and reduced volume of the right anterior cingulate. Psychiatry Res Neuroimaging. 2016;255:24–34. doi:10.1016/j.pscychresns.2016.05.009.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Morales M. The brain on drugs: from reward to addiction. Cell. 2015;162(4):712–25. doi:10.1016/j.cell.2015.07.046.
   PubMed Web of Science ®Google Scholar
• Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159(10):1642–52. doi:10.1176/appi.ajp.159.10.1642.
   PubMed Web of Science ®Google Scholar
• Barrero FJ, Ampuero I, Morales B, Vives F. de Dios Luna Del Castillo J, Hoenicka J, et al. Depression in Parkinson’s disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics J. 2005;5(2):135–41.
   PubMed Web of Science ®Google Scholar
• Monteleone P, Bifulco M, Maina G, Tortorella A, Gazzerro P, Proto MC, Di Filippo C, Monteleone F, Canestrelli B, Buonerba G, et al. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression. Pharmacological Res. 2010;61(5):400–04. doi:10.1016/j.phrs.2010.01.002.
   PubMed Web of Science ®Google Scholar
• Hillard CJ, Weinlander KM, Stuhr KL. Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience. 2012;204:207–29. doi:10.1016/j.neuroscience.2011.11.020.
   PubMed Web of Science ®Google Scholar
• Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neuroscience:Off J Soc Neuroscience. 2001;21(23):9506–18.
   PubMed Web of Science ®Google Scholar
• Witkin JM, Tzavara ET, Nomikos GG. A role for cannabinoid CB1 receptors in mood and anxiety disorders. Behav Pharmacol. 2005;16(5–6):315–31.
   PubMed Web of Science ®Google Scholar
• Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction. 2008;103(10):1678–86. doi:10.1111/j.1360-0443.2008.02292.x.
   PubMed Web of Science ®Google Scholar
• Metrik J, Kahler CW, McGeary JE, Monti PM, Rohsenow DJ. Acute effects of marijuana smoking on negative and positive affect. J Cogn Psychother. 2011;25:31–46. doi:10.1891/0889-8391.25.1.31.
   Google Scholar
• Marlatt GA, Rosenhow DJ. Cognitive processes in alcohol use: expectancy and the balanced placebo design. In: Nk M, editor. Advances in substance abuse: behavioral and biological research. GReenwich: JAI Press; 1980. p. 159–99.
   Google Scholar
• Metrik J, Rohsenow DJ. Understanding the role of substance expectancies in addiction. In: MacKillop J & de Wit H, editor. The Wiley-Blackwell handbook of addiction psychopharmacology. Wiley-Blackwell; 2012. p. 459–87.
   Google Scholar
• Metrik J, Kahler CW, Reynolds B, McGeary JE, Monti PM, Haney M, de Wit H, Rohsenow DJ. Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology. 2012;223(4):489–99. doi:10.1007/s00213-012-2740-y.
   PubMed Web of Science ®Google Scholar
• Cooper ZD, Haney M. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug Alcohol Depend. 2009;103(3):107–13. doi:10.1016/j.drugalcdep.2009.01.023.
   PubMed Web of Science ®Google Scholar
• Foltin RW, Fischman MW, Pedroso JJ, Pearlson GD. Marijuana and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav. 1987;28(4):459–64.
   PubMed Web of Science ®Google Scholar
• Lukas SE, Mendelson JH, Benedikt R. Electroencephalographic correlates of marihuana-induced euphoria. Drug Alcohol Depend. 1995;37(2):131–40.
   PubMed Web of Science ®Google Scholar
• McNair DM, Lorr M, Droppleman LF. Manual for the profile of mood states. San Diego (CA): Educational and Industrial Testing Services, 1992.
   Google Scholar
• Zuo L, Kranzler HR, Luo X, Covault J, Gelernter J. CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry. 2007;62(6):616–26. doi:10.1016/j.biopsych.2006.12.004.
   PubMed Web of Science ®Google Scholar
• Clarke T-K, Bloch PJ, Ambrose-Lanci LM, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O’Brien CP, Oslin DW, et al. Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis. Addict Biol. 2013;18(4):702–08. doi:10.1111/j.1369-1600.2011.00346.x.
   PubMed Web of Science ®Google Scholar
• Zuo L, Kranzler HR, Luo X, Yang B-Z, Weiss R, Brady K, Poling J, Farrer L, Gelernter J. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2009;34(6):1504–13. doi:10.1038/npp.2008.206.
   PubMed Web of Science ®Google Scholar
• Chen X, Williamson VS, An -S-S, Hettema JM, Aggen SH, Neale MC, Kendler KS. Cannabinoid receptor 1 gene association with nicotine dependence. Arch Gen Psychiatry. 2008;65(7):816–24. doi:10.1001/archpsyc.65.7.816.
   PubMed Web of Science ®Google Scholar
• Hill SY, Jones BL, Steinhauer SR, Zezza N, Stiffler S. Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families. Am J Med Genet Part B, Neuropsychiatric Genet: Off Pub Int Soc Psychiatric Genet. 2016;171B(3):383–95. doi:10.1002/ajmg.b.32417.
   PubMedGoogle Scholar
• Hartman CA, Hopfer CJ, Haberstick B, Rhee SH, Crowley TJ, Corley RP, Hewitt JK, Ehringer MA. The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults. Drug Alcohol Depend. 2009;104(1–2):11–16. doi:10.1016/j.drugalcdep.2009.01.022.
   PubMed Web of Science ®Google Scholar
• Herman AI, Kranzler HR, Cubells JF, Gelernter J, Covault J. Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence. Am J Med Genet Part B, Neuropsychiatric Genet: Off Pub Int Soc Psychiatric Genet. 2006;141B(5):499–503. doi:10.1002/ajmg.b.30325.
   PubMed Web of Science ®Google Scholar
• Hirvonen J, Zanotti-Fregonara P, Umhau JC, George DT, Rallis-Frutos D, Lyoo CH, Li C-T, Hines CS, Sun H, Terry GE, et al. Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography. Mol Psychiatry. 2013;18(8):916–21. doi:10.1038/mp.2012.100.
   PubMed Web of Science ®Google Scholar
• Melroy-Greif WE, Wilhelmsen KC, Ehlers CL. Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans. Drug Alcohol Depend. 2016;166:249–53. doi:10.1016/j.drugalcdep.2016.06.021.
   PubMed Web of Science ®Google Scholar
• Sloan ME, Gowin JL, Yan J, Schwandt ML, Spagnolo PA, Sun H, Hodgkinson CA, Goldman D, Ramchandani VA. Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant. Addict Biol. 2018;23(1):474–84. doi:10.1111/adb.12491.
   PubMed Web of Science ®Google Scholar
• Maple KE, McDaniel KA, Shollenbarger SG, Lisdahl KM. Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study. Am J Drug Alcohol Abuse. 2016;42(4):431–40. doi:10.3109/00952990.2016.1141913.
   PubMed Web of Science ®Google Scholar
• Hillard CJ, Liu Q-S. Endocannabinoid signaling in the etiology and treatment of major depressive illness. Curr Pharm Des. 2014;20(23):3795–811.
   PubMed Web of Science ®Google Scholar
• Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B, Godlewski G, Ramikie TS, Gorka AX, Alapafuja SO, et al. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry. 2013;18(7):813–23. doi:10.1038/mp.2012.72.
   PubMed Web of Science ®Google Scholar
• Sham P. Statistics in Human Genetics. New York: Oxford University Press Inc; 1998.
   Google Scholar
• Barrett JC Haploview: visualization and analysis of SNP genotype data. Cold Spring Harbor protocols. 2009;2009(10): pdbip71.
   Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–65. doi:10.1093/bioinformatics/bth457.
   PubMed Web of Science ®Google Scholar
• Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003;73(5):1162–69. doi:10.1086/379378.
   PubMed Web of Science ®Google Scholar
• Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68(4):978–89. doi:10.1086/319501.
   PubMed Web of Science ®Google Scholar
• Yasmin L, Veesenmeyer JL, Diaz MH, Francis MS, Ottmann C, Palmer RH, Hauser, A R., Hallberg, B., et al. Electrostatic interactions play a minor role in the binding of ExoS to 14-3-3 proteins. Biochem J. 2010;427(2):217–24. doi:10.1042/BJ20100043.
   PubMedGoogle Scholar
• IBM_Corp. IBM SPSS statistics for windows. 22.0 ed. Armonk (NY): IBM Corp; Released 2013.
   Google Scholar
• Welsch RE. Regression sensitivity analysis and bounded-influence estimation. In: Kmenta JBR J, editor. Evaluation of econometric models. New York, NY: Academic Press; 1980. p. 153–67.
   Google Scholar
• Re W. Regression sensitivity analysis and bounded-influence estimation. In: K J, Jb R, editors. Evaluation of econometric models. New York, NY: Academic Press; 1980. p. 153–67.
   Google Scholar
• Filbey FM, Dunlop J, Ketcherside A, Baine J, Rhinehardt T, Kuhn B, DeWitt S, Alvi T. fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users. Hum Brain Mapp. 2016;37(10):3431–43. doi:10.1002/hbm.23250.
   PubMed Web of Science ®Google Scholar
• Brown SA. Drug effect expectancies and addictive behavior change. Exp Clin Psychopharmacol. 1993;1(1–4):55–67. doi:10.1037/1064-1297.1.1-4.55.
   Web of Science ®Google Scholar
• Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neuroscience:Off J Soc Neuroscience. 2004;24(47):10707–15. doi:10.1523/JNEUROSCI.3502-04.2004.
   PubMed Web of Science ®Google Scholar
• Rubino T, Prini P, Piscitelli F, Zamberletti E, Trusel M, Melis M, Sagheddu C, Ligresti A, Tonini R, Di Marzo V, et al. Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex. Neurobiol Dis. 2015;73:60–69. doi:10.1016/j.nbd.2014.09.015.
   PubMed Web of Science ®Google Scholar
• Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet. 2004;13(18):2113–19. doi:10.1093/hmg/ddh216.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Pergadia ML, Saccone SF, Lynskey MT, Wang JC, Martin NG, Statham D, Henders A, Campbell M, Garcia R, et al. An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project. Arch Gen Psychiatry. 2008;65(6):713–21. doi:10.1001/archpsyc.65.6.713.
   PubMed Web of Science ®Google Scholar
• Carey CE, Agrawal A, Zhang B, Conley ED, Degenhardt L, Heath AC, Li D, Lynskey MT, Martin NG, Montgomery GW, et al. Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: evidence from an endocannabinoid system-level analysis. J Abnorm Psychol. 2015;124(4):860–77. doi:10.1037/abn0000079.
   PubMed Web of Science ®Google Scholar
• Ehlers CL, Slutske WS, Lind PA, Wilhelmsen KC. Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians. Twin Res Hum Genet:Off J Int Soc Twin Stud. 2007;10(6):805–11. doi:10.1375/twin.10.6.805.
   PubMed Web of Science ®Google Scholar
• Mitjans M, Serretti A, Fabbri C, Gastó C, Catalán R, Fañanás L, Arias B. Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment. Psychopharmacology. 2013;227(3):509–19. doi:10.1007/s00213-013-2995-y.
   PubMed Web of Science ®Google Scholar
• ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in Cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States. Biol Psychiatry. 2016;79(7):613–19. doi:10.1016/j.biopsych.2016.01.004.
   PubMed Web of Science ®Google Scholar
• Rodriguez D Washington State Marijuana Impact Report: Northwest High Intensity Drug Trafficking Area. 2016.
   Google Scholar
• Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2018;43(1):195–212. doi:10.1038/npp.2017.198.
   PubMed Web of Science ®Google Scholar
• López-Moreno JA, Echeverry-Alzate V, Bühler KM. The genetic basis of the endocannabinoid system and drug addiction in humans. J Psychopharmacol. 2012;26(1):133–43. doi:10.1177/0269881111416689.
   PubMed Web of Science ®Google Scholar